Login to your account
Don’t have an account?
Create a Free Account
x
Filter:
Filters applied
- Research Letters
- LetterRemove Letter filter
- Armbrust, Karen RRemove Armbrust, Karen R filter
- Maxey, Amy GarboRemove Maxey, Amy Garbo filter
- Santilli, Christopher MRemove Santilli, Christopher M filter
- Lattery, Christine ARemove Lattery, Christine A filter
Publication Date
Please choose a date range between 2021 and 2021.
Research Letters
1 Results
- Research Letter
Accuracy of self-reported risk factors for hydroxychloroquine retinopathy
Canadian Journal of OphthalmologyVol. 57Issue 1p65–66Published online: February 16, 2021- Christopher M. Santilli
- Amy Garbo Maxey
- Christine A. Lattery
- Emmett F. Carpel
- Karen R. Armbrust
Cited in Scopus: 0Hydroxychloroquine (HCQ) is an effective and typically well-tolerated anti-inflammatory medication, but retinal toxicity is a potential side effect.1 Current screening guidelines recommend baseline ophthalmic examination to rule out maculopathy and then yearly examination with visual field and optical coherence tomography after 5 years of HCQ use.1 The presence of HCQ retinopathy risk factors,2 such as HCQ duration ≥5 years, HCQ daily dose >5 mg/kg real body weight, tamoxifen use, or renal disease, should increase suspicion for retinopathy and may modify the retinopathy screening timeline.
